Last reviewed · How we verify
NCT02854137
Evaluation of the Irritation Potential of Sunscreen Products in Human Eyes
NA trial testing BAY987521 in Sunscreening Agents in 23 participants. Completed in 14 October 2015.
14 October 2015
Quick facts
| Lead sponsor | Bayer |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | other |
| Enrollment | 23 |
| Start date | 14 October 2015 |
| Primary completion | 14 October 2015 |
| Estimated completion | 14 October 2015 |
| Sites | 1 location across United States |
Drugs / interventions tested
- BAY987521 — full drug profile →
- Control
Conditions studied
- Sunscreening Agents — all drugs for Sunscreening Agents →
Sponsor
Bayer — full company profile →
Who can join
Adults 18 to 60, any sex, with Sunscreening Agents. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Evaluation of the human eye irritation potential of a test sunscreen formulation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02854137
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of BAY987521
Trials testing the same drug.
- NCT02995109 — Sun Protection Factor Assay (338/2016) · NA · completed
- NCT02995044 — Sun Protection Factor Assay (319/2016) · NA · terminated
- NCT02995018 — Sun Protection Factor Assay (317/2016) · NA · completed
- NCT02995031 — Sun Protection Factor Assay (318/2016) · NA · terminated
- NCT02995148 — Sun Protection Factor Assay (343/2016) · NA · completed
Other Bayer trials
Trials by the same sponsor.
- NCT05900388 — A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolis · not yet recruiting
- NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
- NCT05477953 — An Observational Pregnancy Safety Study in Women Who Were Exposed to the Drug Nifurtimox During Pregnancy to Learn About · not yet recruiting
- NCT07192952 — A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child · Phase 3 · not yet recruiting
- NCT07450599 — A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Befo · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02854137 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bayer
- Last refreshed: 12 December 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02854137.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing